FDA Drug Recalls

14,806 recalls, newest first

Apr 13, 2022 Class II · Moderate risk

Recothrom Thrombin Topical

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0338-0322-01 D-1082-2022

Apr 13, 2022 Class II · Moderate risk

Revonto (dantrolene sodium for injection)

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 78670-003-67 D-1081-2022

Apr 13, 2022 Class II · Moderate risk

Revonto (dantrolene sodium for injection)

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 27505-003-67 D-1080-2022

Apr 13, 2022 Class II · Moderate risk

Vecuronium Bromide for Injection

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0703-2914-03 D-1079-2022

Apr 13, 2022 Class II · Moderate risk

Propofol Injectable Emulsion

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0591-2136-95 D-1078-2022

Apr 13, 2022 Class II · Moderate risk

Propofol Injectable Emulsion

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 00591-2136-51 D-1077-2022

Apr 13, 2022 Class II · Moderate risk

Proair

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 59310-579-22 D-1076-2022

Apr 13, 2022 Class II · Moderate risk

Mupirocin Ointment

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0093-1010-42 D-1075-2022

Apr 13, 2022 Class II · Moderate risk

MethyLPREDNISolone Acetate Injectable Suspension USP

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0703-0063-01 D-1074-2022

Apr 13, 2022 Class II · Moderate risk

MethyLPREDNISolone Acetate Injectable Suspension USP

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0703-0051-01 D-1073-2022

Apr 13, 2022 Class II · Moderate risk

MethyLPREDNISolone Acetate Injectable Suspension USP

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0703-0045-01 D-1072-2022

Apr 13, 2022 Class II · Moderate risk

MethyLPREDNISolone Acetate Injectable Suspension

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0703-0043-01 D-1071-2022

Apr 13, 2022 Class II · Moderate risk

MethyLPREDNISolone Acetate Injectable Suspension

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0703-0031-01 D-1070-2022

Apr 13, 2022 Class II · Moderate risk

Medroxyprogesterone acetate injectable suspension

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0703-6801-01 D-1069-2022

Apr 13, 2022 Class II · Moderate risk

Lidocaine Patch 5%

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0591-3525-30 D-1068-2022

Apr 13, 2022 Class II · Moderate risk

Levalbuterol Tartrate HFA Inhalation Aerosol

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0591-2927-54 D-1067-2022

Apr 13, 2022 Class II · Moderate risk

Clonidine Hydrochloride Tablets

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 00228-2127-10 D-1066-2022

Apr 13, 2022 Class II · Moderate risk

Ketoconazole Cream

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0168-0099-60 D-1065-2022

Apr 13, 2022 Class II · Moderate risk

MethyLPREDNISolone Acetate Injectable Suspension USP

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 16714-473-01 D-1064-2022

Apr 13, 2022 Class II · Moderate risk

MethyLPREDNISolone Acetate Injectable Suspension

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 16714-090-01 D-1063-2022

Apr 13, 2022 Class II · Moderate risk

MethyLPREDNISolone Acetate Injectable Suspension

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 16714-089-01 D-1062-2022

Apr 13, 2022 Class II · Moderate risk

MethyLPREDNISolone Acetate Injectable Suspension USP

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 6714-088-01 D-1061-2022

Apr 13, 2022 Class II · Moderate risk

Medroxyprogesterone acetate injectable suspension

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 16714-981-01 D-1060-2022

Apr 13, 2022 Class II · Moderate risk

Sulfamethoxazole and Trimethoprim Tablets

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0904-2725-61 D-1059-2022

Apr 13, 2022 Class II · Moderate risk

Sodium Bicarbonate Tablets

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0536-1047-10 D-1058-2022

Recalls by year

2026563
2025778
2024557
20231,122
20221,390
20211,152
2020930
20191,788
20181,681
20171,141
20161,199
20151,733
20141,309
20132,085
2012534
201134
20104
20072
20061